vs

Side-by-side financial comparison of ALLIENT INC (ALNT) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

ALLIENT INC is the larger business by last-quarter revenue ($143.4M vs $142.0M, roughly 1.0× Oncology Institute, Inc.). ALLIENT INC runs the higher net margin — 4.5% vs -5.3%, a 9.7% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 17.5%). ALLIENT INC produced more free cash flow last quarter ($11.7M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs -1.2%).

Allient Inc is a global technology and manufacturing firm that designs, produces, and distributes precision motion, control, and power solutions. It serves core segments including aerospace, defense, medical, industrial automation, and commercial mobility, with operations across North America, Europe, and Asia-Pacific.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

ALNT vs TOI — Head-to-Head

Bigger by revenue
ALNT
ALNT
1.0× larger
ALNT
$143.4M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+24.1% gap
TOI
41.6%
17.5%
ALNT
Higher net margin
ALNT
ALNT
9.7% more per $
ALNT
4.5%
-5.3%
TOI
More free cash flow
ALNT
ALNT
$9.5M more FCF
ALNT
$11.7M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
-1.2%
ALNT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALNT
ALNT
TOI
TOI
Revenue
$143.4M
$142.0M
Net Profit
$6.4M
$-7.5M
Gross Margin
32.4%
Operating Margin
7.9%
-4.9%
Net Margin
4.5%
-5.3%
Revenue YoY
17.5%
41.6%
Net Profit YoY
111.8%
43.0%
EPS (diluted)
$0.38
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALNT
ALNT
TOI
TOI
Q4 25
$143.4M
$142.0M
Q3 25
$138.7M
$136.6M
Q2 25
$139.6M
$119.8M
Q1 25
$132.8M
$104.4M
Q4 24
$122.0M
$100.3M
Q3 24
$125.2M
$99.9M
Q2 24
$136.0M
$98.6M
Q1 24
$146.7M
$94.7M
Net Profit
ALNT
ALNT
TOI
TOI
Q4 25
$6.4M
$-7.5M
Q3 25
$6.5M
$-16.5M
Q2 25
$5.6M
$-17.0M
Q1 25
$3.6M
$-19.6M
Q4 24
$3.0M
$-13.2M
Q3 24
$2.1M
$-16.1M
Q2 24
$1.1M
$-15.5M
Q1 24
$6.9M
$-19.9M
Gross Margin
ALNT
ALNT
TOI
TOI
Q4 25
32.4%
Q3 25
33.3%
Q2 25
33.2%
Q1 25
32.2%
Q4 24
31.5%
Q3 24
31.4%
Q2 24
29.9%
Q1 24
32.3%
Operating Margin
ALNT
ALNT
TOI
TOI
Q4 25
7.9%
-4.9%
Q3 25
8.8%
-5.9%
Q2 25
8.4%
-9.4%
Q1 25
6.6%
-9.5%
Q4 24
5.3%
-11.9%
Q3 24
5.3%
-13.9%
Q2 24
3.6%
-16.6%
Q1 24
8.2%
-19.0%
Net Margin
ALNT
ALNT
TOI
TOI
Q4 25
4.5%
-5.3%
Q3 25
4.7%
-12.1%
Q2 25
4.0%
-14.2%
Q1 25
2.7%
-18.8%
Q4 24
2.5%
-13.1%
Q3 24
1.7%
-16.1%
Q2 24
0.8%
-15.7%
Q1 24
4.7%
-21.0%
EPS (diluted)
ALNT
ALNT
TOI
TOI
Q4 25
$0.38
$-0.04
Q3 25
$0.39
$-0.14
Q2 25
$0.34
$-0.15
Q1 25
$0.21
$-0.21
Q4 24
$0.17
$-0.14
Q3 24
$0.13
$-0.18
Q2 24
$0.07
$-0.17
Q1 24
$0.42
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALNT
ALNT
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$40.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$301.5M
$-15.7M
Total Assets
$577.6M
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALNT
ALNT
TOI
TOI
Q4 25
$40.7M
Q3 25
$39.5M
Q2 25
$49.9M
Q1 25
$47.8M
Q4 24
$36.1M
Q3 24
$37.1M
Q2 24
$31.3M
$9.9M
Q1 24
$31.5M
$29.8M
Stockholders' Equity
ALNT
ALNT
TOI
TOI
Q4 25
$301.5M
$-15.7M
Q3 25
$294.2M
$-12.3M
Q2 25
$289.1M
$-9.0M
Q1 25
$272.8M
$5.1M
Q4 24
$264.9M
$3.6M
Q3 24
$272.9M
$15.5M
Q2 24
$265.7M
$29.2M
Q1 24
$267.1M
$41.3M
Total Assets
ALNT
ALNT
TOI
TOI
Q4 25
$577.6M
$164.7M
Q3 25
$585.1M
$163.6M
Q2 25
$588.1M
$159.8M
Q1 25
$586.9M
$164.0M
Q4 24
$575.8M
$172.7M
Q3 24
$596.4M
$179.2M
Q2 24
$595.8M
$179.6M
Q1 24
$611.6M
$204.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALNT
ALNT
TOI
TOI
Operating Cash FlowLast quarter
$13.6M
$3.2M
Free Cash FlowOCF − Capex
$11.7M
$2.2M
FCF MarginFCF / Revenue
8.1%
1.5%
Capex IntensityCapex / Revenue
1.3%
0.7%
Cash ConversionOCF / Net Profit
2.12×
TTM Free Cash FlowTrailing 4 quarters
$49.7M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALNT
ALNT
TOI
TOI
Q4 25
$13.6M
$3.2M
Q3 25
$4.7M
$-12.6M
Q2 25
$24.5M
$-10.2M
Q1 25
$13.9M
$-5.0M
Q4 24
$12.4M
$4.2M
Q3 24
$12.1M
$819.0K
Q2 24
$8.2M
$-15.7M
Q1 24
$9.2M
$-15.9M
Free Cash Flow
ALNT
ALNT
TOI
TOI
Q4 25
$11.7M
$2.2M
Q3 25
$2.8M
$-13.2M
Q2 25
$22.4M
$-11.4M
Q1 25
$12.9M
$-5.3M
Q4 24
$9.6M
$2.4M
Q3 24
$10.5M
$417.0K
Q2 24
$5.8M
$-17.5M
Q1 24
$6.2M
$-16.5M
FCF Margin
ALNT
ALNT
TOI
TOI
Q4 25
8.1%
1.5%
Q3 25
2.0%
-9.7%
Q2 25
16.0%
-9.5%
Q1 25
9.7%
-5.1%
Q4 24
7.9%
2.4%
Q3 24
8.4%
0.4%
Q2 24
4.3%
-17.7%
Q1 24
4.2%
-17.4%
Capex Intensity
ALNT
ALNT
TOI
TOI
Q4 25
1.3%
0.7%
Q3 25
1.4%
0.4%
Q2 25
1.5%
1.0%
Q1 25
0.8%
0.3%
Q4 24
2.3%
1.8%
Q3 24
1.3%
0.4%
Q2 24
1.7%
1.9%
Q1 24
2.0%
0.6%
Cash Conversion
ALNT
ALNT
TOI
TOI
Q4 25
2.12×
Q3 25
0.72×
Q2 25
4.36×
Q1 25
3.92×
Q4 24
4.11×
Q3 24
5.75×
Q2 24
7.13×
Q1 24
1.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALNT
ALNT

Industrial And Electronics$69.5M48%
Vehicle$25.7M18%
Other$20.9M15%
Aerospace And Defense$20.6M14%
Distribution And Other Target Market$6.7M5%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons